Ainara Estanga Alustiza-rekin lankidetzan egindako argitalpenak (7)

2016

  1. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2R1441G Parkinson's disease

    Movement Disorders, Vol. 31, Núm. 3, pp. 335-343

2014

  1. Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2

    Parkinsonism and Related Disorders, Vol. 20, Núm. 10, pp. 1097-1100

  2. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

    Movement Disorders, Vol. 29, Núm. 6, pp. 750-755

2013

  1. Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers

    Neurobiology of Aging, Vol. 34, Núm. 5, pp. 1462-1468

2012

  1. Neuropsychological features of asymptomatic c.709-1G>A progranulin mutation carriers

    Journal of the International Neuropsychological Society, Vol. 18, Núm. 6, pp. 1086-1090

2010

  1. A Novel PRNP Y218N mutation in gerstmann-sträussler-scheinker disease with neurofibrillary degeneration

    Journal of Neuropathology and Experimental Neurology, Vol. 69, Núm. 8, pp. 789-800

2009

  1. Frontotemporoparietal dementia: Clinical phenotype associated with the c.709-1G>A PGRN mutation

    Neurology, Vol. 73, Núm. 17, pp. 1367-1374